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Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenlc diabetes Insipidus. Congenital nephrogenic diabetes insipidus (ND!) is an X-linked recessive disease characterized by insensitivity of the distal nephron to the antidiuretic effect of arginine vasopressin. The hypothesis that the defect underlying NDI might be a dysfunctional renal vasopressin V receptor has recently been proven by the identification of mutations in the V2 receptor gene in ND! patients. We examined thirteen unrelated Dutch ND! families and identified thirteen distinct and unique mutations. These included nine missense mutations, two nonsense mutations and two small deletions and were found in the extracellular domains II, ifi and IV, the intracellular domains!! and IV and in the transmembrane loops I, II, IV and V of the vasopressin type 2 receptor. In the families with multiple NDI patients the mutated gene cosegregated with the disease. Our data suggest a higher mutation frequency in male than in female gametes. No discrepancies between carrier detection by means of DNA analysis with closely linked polymorphic markers and the definite diagnosis based on sequencing data were found.
Congenital nephrogenic diabetes insipidus (NDI) is mostly an X-linked recessive disease, characterized by renal resistance to the antidiuretic effect of arginine vasopressin. The disorder becomes manifest early in infancy with polyuria, periods of life-threatening dehydration, fever, anorexia, vomiting and failure to thrive. Without treatment, mental retardation may develop probably due to brain dehydration. Until recently, the molecular basis underlying ND! was unknown. The neurohypophyseal hormone arginine vasopressin (AVP) exerts its physiological effects through stimulation of at least two distinct (i-protein-coupled receptors, vasopressin V1 and V2 receptors [1] . The vascular V1 receptor, which is connected to a phosphoinositide specific phospholipase and Ca2 mobilization, mediates vasoconstrictor and glycogenolytic responses; the renal tubular V2 receptor, which is connected to the membranebound adenylate cyclase and stimuiation of cyclic AMP, mediates the antidiuretic response to vasopressin.
In addition to mediating antidiuresis, an apparent V2 mediated action of AVP and its V2-specific agonist, l-desamino-8-D-arginine vasopressin (DDAVP), causes release of coagulation and fibrinolytic factors (2] and vasodilation [3] . These extra-Received for publication August 11, 1993 and in revised form January 24, 1994 Accepted for publication January 24, 1994 © 1994 by the International Society of Nephrology renal responses are also absent in NDI patients [4] [5] [6] , suggesting that the defect in this disorder might be a dysfunctional or nonfunctional vasopressin V2 receptor.
In the last five years the understanding of the genetics and pathogenesis of X-linked ND! has expanded considerably. The beginning of the era of studying NDI was marked by the localization of the disease gene to the distal region of the X chromosome long arm, to Xq28 [7, 8] . The next step was the discovery of functional vasopressin V2 receptor activity in somatic cell hybrids that carried at least the terminal region of the human X chromosome (Xqter) [9, 10] . This finding supported the assumption that the ND! gene and the vasopressin V2 receptor gene might be identical. Very recently, the cloning of the V2 receptor gene from human [11] and rat [121 was reported. The V2 receptor gene encodes a G-protein coupled receptor protein containing seven putative transmembrane helices with considerable sequence homology to the V1 vasopressin and oxytocin receptors.
Definite proof for a vasopressin V2 receptor defect being the cause of ND! was obtained with the identification of mutations in the V2 receptor gene in ND! patients [13] [14] [15] [16] [17] [18] .
In this article we report mutations in the V2 receptor gene in 13 Dutch NDI families. The implications for genetic counseling are discussed.
Methods

Study subjects
Thirteen ND! families from the Netherlands were included in the study. All patients were males, eight of them being sporadic cases, whereas in five families transmission was compatible with X-linkage. Diagnosis of ND! was based on clinical symptoms and lack of increase of urinary osmolality after administration of the synthetic vasopressin analogue DDAVP. Maximal urine osmolalities that could be achieved after DDAVP infusion were 51 to 198 mOsmollkg (normal.> 805 mOsmol/kg).
DNA analysis
Procedures for the isolation of genomic DNA from patient blood cells as well as Southern blotting analysis have been described elsewhere [7, 81. The additional markers tested were an MspI polymorphism at the locus DXS3O4 [19] , a BstYI polymorphism at the locus DXS455 [20] , a TaqI polymorphism at the locus DXS3O5 [21] , an MspI polymorphism at locus 170 -- [11] b Abbreviations are: E, extracellular domain; C, intracellular domain; TM, transmembrane region of the proposed topology of the V2 receptor protein [11, 12] The order of loci is derived from the latest X chromosome workshop report [24] . Abbreviation is AVPR2, vasopressin V2 receptor gene.
DXS7O7, an EcoRl polymorphism at the DXS6O5 locus [22] , and a CA repeat at the F8 locus [23] . The allele sizes of most of these polymorphisms are listed in the last Human Gene Mapping report [24] and the localization of the markers with respect to the ND! locus is depicted in Figure 1 . Direct automated DNA sequence analysis on both strands of genomic patient DNA was performed as described previously [17] .
Results
The mutations in V2 receptor gene found in the probands of each family are shown in Table 1 . Thirteen distinct mutations were identified: two small deletions, two nonsense mutations and nine missense mutations. These mutations are not clustered in one domain of the V2 receptor protein but are found throughout almost the whole receptor, in the extracellular domains II, III, and IV, the intracellular domains II and IV, and the transmembrane loops I, II, IV, and V. Mter the mutation in the affected probands in each family had been characterized, other family members were screened either by restriction enzyme analysis (for example, family 024/ND, Fig. 2 ) or, when this was not possible by direct sequencing of genomic DNA. In each of the five families with multiple NDI patients, the mutation identified in the proband was found in all other patients but not in the unaffected males of that particular family.
In seven families NDI was due to a de novo mutation. By combining haplotypes of DNA markers flanking the vasopressin receptor gene with mutation data in each of these seven families, the origin of the mutation was deduced in six of them. In four families the mutation occurred most likely during male Fig. 2 . Segregation of a point mutation in the V2 receptor gene in family 024/ND followed by restriction enzyme digestion. The mutation found in the proband resulted in the loss of a BsrI site. The region around the mutation was amplified with the primers 5'TGGCTCTGT-TCCAAGTGCTG3' (position 263-282 [11] ) and 5'CAGGTGACATAG-GTGCGACG3' (position 603-623 [11] ). PCR was performed as descibed previously [17] . The PCR product was digested with BsrI and the fragments were resolved on a 3% agarose gel and stained with ethidium bromide. For the mutant allele the PCR product of 360 bp was not cleaved by BsrI, while the wild type allele gave two fragments. The sizes of the PCR fragments as deduced by comparison with DNA fragment length standards (not shown) were in agreement with the sizes predicted on the basis of the published V2 receptor eDNA sequence.
The mother of the patient shows three bands, indicative for heterozygosity. In the lanes of the PCR fragments of the wild type alleles a very faint band at the position of the uncleaved PCR product is still visible, which is of no significance. Solid symbol represents the affected individual. meiosis: during spermatogenesis in the maternal grandfather in three families (Fig. 3 a,b,c) and in the maternal great-grandfather in one family (Fig. 3d ). In two families the mutation arose during female meiosis: during oogenesis in the mother in one family ( Fig. 3e ) and in the maternal grandmother in the other family ( Fig. 30 . In family 046/ND (Fig. 3g) the origin of the mutation could not be determined, either during spermatogen- 
Discussion
The assumption that the NDI gene might be identical to the vasopressin V2 receptor gene has recently been confirmed by the identification of several mutations in the V2 receptor gene in [14] reported six unique mutations in the V2 receptor gene of five unrelated NDI patients with one patient having two mutations. In the latter patient a point mutation causing an Arg-188-Cys missense mutation and a 1 bp deletion was found. Very recently, three other groups published distinct defects in the V2 receptor gene in patients with NDI [15, 16, 18] . In a previous report [17] we have described the identification of point mutations in three of our ND! patients. These mutations resulted in non-conservative amino acid substitutions in the strongly conserved third extracellular domain of the receptor protein.
In the present study we have examined the inheritance of mutations in the V2 receptor gene in 13 additional Dutch unrelated ND! families. The mutations identified in the 13 probands are unique and include two small deletions, two nonsense mutations, and ten missense mutations and were found in the extracellular domains II, III and IV, the intracellular domains II and IV and in the transmembrane loops I, II, IV, and V. In the families with multiple NDI patients the mutated V2 receptor gene cosegregated with the disease. The finding of diverse mutations indicates that ND! is heterogeneous at the molecular level, as expected for a typical X-linked disorder with reduced reproductive fitness in affected males.
After the identification of closely-linked polymorphic DNA markers [7, 8] in 1987, the carrier status in females at risk could be determined by DNA linkage analysis. The reliability of this method depends upon the genetic distance between the markers and the mutation causing the disease. Although the recombination frequency between the available DNA markers and the NDI gene is very low [10] , linkage analysis can never establish a diagnosis with absolute certainty. A 100% accurate diagnosis is now possible with direct mutation analysis. In this study no discrepancies were found between the carrier status determined by linkage analysis and the definite diagnosis based on sequencing data.
In seven families (pedigrees 018, 023, 024, 027, 046, 362, and 456), it was demonstrated that ND! was due to a de novo mutation. In six of these cases the patients' mother was shown to be a gene carrier; thus in these families the mutated gene originated from the maternal (great)grandparents. In one family (pedigree 046) it was not possible to deduce the origin of the mutation. Remarkably, in only one of the other five families (pedigree 456) the mutation appeared to be on the X chromosome that was derived from the maternal grandmother. In the other cases the mutated gene was shown to be on the X chromosome that came from either the maternal grandfather (pedigree 018, 023, 024) or from the maternal great-grandfather (pedigree 362). Although these numbers are small, they are consistent with the theory that the mutation rate in the male germline might be higher than in female germline [25] [26] [27] . Direct mutation analysis of a large number of families with isolated cases of NDI is necessary to define the exact mutation fre-quency for ND! in male and female gametes. Knowledge of the sex ratios of mutation frequencies has implications for genetic counseling in families with isolated cases. If the mutation frequency is indeed higher in males than in females, a high proportion of the mothers of isolated patients will be carriers of the gene. In summary, we identified thirteen distinct and unique mutations in thirteen unrelated ND! families. Our data suggest the possibility of a higher mutation frequency in males than in females, and underscore the reliabilty of linkage analysis for heterozygote detection in NDI.
